Tina-Quant Myoglobin GEN.2 Test System

FDA 510(k) K061683 · Roche Diagnostics Corp.

Substantially Equivalent

510(k) numberK061683

Submission

Device name
Tina-Quant Myoglobin GEN.2 Test System
Applicant
Roche Diagnostics Corp.
Indianapolis, IN, US
Received
June 15, 2006
Decision date
July 21, 2006
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
DDR – Myoglobin, Antigen, Antiserum, Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5680
Specialty
Immunology

Other 510(k)s with product code DDR

510(k)DeviceApplicantDecision
K231832Access MyoglobinDDR · Traditional Beckman Coulter, Inc.09/18/2023SE
K123785Diazyme Myoglobin; Assay, Calibrator Set, Control SetDDR · Traditional Diazyme Laboratories06/07/2013SE
K122599Advia Chemistry Myoglobin Reagent, Advia Chemistry Myoglbin CalibratorDDR · Traditional Siemens Healthcare Diagnostics, Inc.10/03/2012SE
K083260Elecsys Myoglobin Stat, and Elecsys MyoglobinDDR · Traditional Roche Diagnostics10/16/2009SE
K080481Access Immunoassay Systems Myoglobin and Access Immunoassay Systems Myoglobin CalibratorsDDR · Traditional Beckman Coulter, Inc.02/20/2009SE
K042924Architect Stat Myo ImmunoassayDDR · Traditional Fisher Diagnostics01/24/2005SE
K042982Quantex MyoglobinDDR · Traditional Instrumentation Laboratory CO12/22/2004SE
K033300Vitros Immunodiagnostic Products Myoglobin Reagent Pack; Calibrators; Range VerifiersDDR · Traditional Ortho-Clinical Diagnostics, Inc.11/05/2003SE
K021229Myoglobin and Myoglobin Calibrators on the Access Immunoassay Systems, Model 973243…DDR · Traditional Beckman Coulter, Inc.06/28/2002SE
K012040Ramp Myoglobin AssayDDR · Traditional Response Biomedical Corp.12/18/2001SE

More from Response Biomedical Corp.

510(k)DeviceDecision
K261686Elecsys Phospho-Tau (217P) PlasmaSET · Traditional 08/19/2026SE
K252323cobas pulse blood glucose monitoring systemPZI · Dual Track 06/12/2026SE
K252431Elecsys CalcitoninJKR · Traditional 04/24/2026SE
K252280Elecsys Anti-SARS-CoV-2 SQVP · Traditional 04/13/2026SE
K260049Elecsys Anti-HBc IgMSEI · Traditional 04/07/2026SE
K260048Elecsys Anti-HAV IgMLOL · Traditional 04/07/2026SE
K260046Elecsys Anti-HBc IISEI · Traditional 04/07/2026SE
K260026Tina-quant Cardiac high sensitivity CRP IIINQD · Traditional 04/02/2026SE
K253491ISE indirect K for Gen.2; ISE indirect Na for Gen.2; ISE indirect Cl for Gen.2; cobas…CEM · Traditional 02/12/2026SE
K253490Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsCFR · Traditional 02/12/2026SE

Questions and answers

When was Tina-Quant Myoglobin GEN.2 Test System cleared by the FDA?

Tina-Quant Myoglobin GEN.2 Test System (K061683) received a 510(k) decision of Substantially Equivalent on July 21, 2006, 36 days after the submission was received.

What is the product code of K061683?

The FDA product code is DDR – Myoglobin, Antigen, Antiserum, Control, a Class II (moderate risk) device regulated under 21 CFR 866.5680.